Literature DB >> 21600974

Carmustine induces ERK- and JNK-dependent cell death of neuronally-differentiated PC12 cells via generation of reactive oxygen species.

Jeong Mi An1, Seon Sook Kim, Jin Hak Rhie, Dong Min Shin, Su Ryeon Seo, Jeong Taeg Seo.   

Abstract

Accumulation of reactive oxygen species (ROS) caused by the inhibition of glutathione reductase (GR) has been proposed as one of the mechanisms responsible for carmustine (1,3-bis(2-chloroethyl)-1-nitrosourea, BCNU)-induced cytotoxicity. Since mitogen-activated protein kinases (MAPKs) are known to mediate ROS-dependent cell death in multiple cell types, we examined whether redox-sensitive MAPK activation mediated the carmustine-induced cell death of neuronally differentiated PC12 cells. Carmustine induced a concentration- and time-dependent cell death, which was associated with increased caspase-3 activation, a reduction in GR activity accompanied by a concomitant decrease in reduced glutathione levels, and accumulation of ROS. Carmustine-induced caspase-3 activation and cell death were prevented by pretreatment with anti-oxidants or a reducing agent, indicating that carmustine-induced caspase-3 activation and cell death occur via redox-dependent processes. Carmustine induced phosphorylation of the MAPKs, such as extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. The activation of these kinases was inhibited by pretreatment with N-acetyl-L-cysteine (NAC). Although all the MAPKs were activated by carmustine, only the inhibitors of JNK and ERK prevented carmustine-induced cell death and caspase-3 activation. Our data suggest that carmustine-induced neurotoxicity is, at least in part, due to the activation of ROS-dependent JNK and ERK signaling.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21600974     DOI: 10.1016/j.tiv.2011.05.006

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  8 in total

Review 1.  Plausible biochemical mechanisms of chemotherapy-induced cognitive impairment ("chemobrain"), a condition that significantly impairs the quality of life of many cancer survivors.

Authors:  Xiaojia Ren; Diana Boriero; Luksana Chaiswing; Subbarao Bondada; Daret K St Clair; D Allan Butterfield
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2019-02-10       Impact factor: 5.187

Review 2.  Chemotherapy-induced cognitive impairment: focus on the intersection of oxidative stress and TNFα.

Authors:  Nicole G Rummel; Luksana Chaiswing; Subbarao Bondada; Daret K St Clair; D Allan Butterfield
Journal:  Cell Mol Life Sci       Date:  2021-08-23       Impact factor: 9.207

Review 3.  The Tumorigenic Roles of the Cellular REDOX Regulatory Systems.

Authors:  Stéphanie Anaís Castaldo; Joana Raquel Freitas; Nadine Vasconcelos Conchinha; Patrícia Alexandra Madureira
Journal:  Oxid Med Cell Longev       Date:  2015-11-22       Impact factor: 6.543

Review 4.  The Role of Oxidative Stress in Etiopathogenesis of Chemotherapy Induced Cognitive Impairment (CICI)-"Chemobrain".

Authors:  Amelia Maria Gaman; Adriana Uzoni; Aurel Popa-Wagner; Anghel Andrei; Eugen-Bogdan Petcu
Journal:  Aging Dis       Date:  2016-05-27       Impact factor: 6.745

5.  A linear programming computational framework integrates phosphor-proteomics and prior knowledge to predict drug efficacy.

Authors:  Zhiwei Ji; Bing Wang; Ke Yan; Ligang Dong; Guanmin Meng; Lei Shi
Journal:  BMC Syst Biol       Date:  2017-12-21

Review 6.  Neuroprotective Effects of Bioactive Compounds and MAPK Pathway Modulation in "Ischemia"-Stressed PC12 Pheochromocytoma Cells.

Authors:  Adi Lahiani; Annette Brand-Yavin; Ephraim Yavin; Philip Lazarovici
Journal:  Brain Sci       Date:  2018-02-08

7.  Apoptosis induced by temozolomide and nimustine in glioblastoma cells is supported by JNK/c-Jun-mediated induction of the BH3-only protein BIM.

Authors:  Maja T Tomicic; Ruth Meise; Dorthe Aasland; Nancy Berte; Rebekka Kitzinger; Oliver H Krämer; Bernd Kaina; Markus Christmann
Journal:  Oncotarget       Date:  2015-10-20

8.  Development and Application of High-Content Biological Screening for Modulators of NET Production.

Authors:  Ilaria J Chicca; Michael R Milward; Iain Leslie C Chapple; Gareth Griffiths; Rod Benson; Thomas Dietrich; Paul R Cooper
Journal:  Front Immunol       Date:  2018-03-05       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.